Wednesday, March 23, 2016

UPDATE 1-AstraZeneca heart drug fails in key stroke trial

* Failure is setback for $3.5 billion drug sales target (Adds sales forecasts, background)

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)